Do analysts rate ACB or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media refer more to ACB or OGI?

In the previous week, Aurora Cannabis had 3 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Aurora Cannabis and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Aurora Cannabis' score of 0.75 indicating that Organigram Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer OGI or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Does the media favor OGI or CGC?

In the previous week, Canopy Growth had 8 more articles in the media than Organigram Global. MarketBeat recorded 10 mentions for Canopy Growth and 2 mentions for Organigram Global. Canopy Growth's average media sentiment score of 1.01 beat Organigram Global's score of 0.94 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 5 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CRON or OGI?

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media prefer CRON or OGI?

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Cronos Group and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Cronos Group's score of 0.63 indicating that Organigram Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend SNDL or OGI?

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 254.61%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, SNDL or OGI?

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.54 -$11.29M -$0.03 N/A Organigram Global $185.07M 0.81 -$17.70M -$0.13 N/A

Is SNDL or OGI more profitable?

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -1.19% -1.02% -0.85% Organigram Global -9.22% -13.41% -9.09%

Does the media favor SNDL or OGI?

In the previous week, SNDL had 4 more articles in the media than Organigram Global. MarketBeat recorded 6 mentions for SNDL and 2 mentions for Organigram Global. SNDL's average media sentiment score of 1.06 beat Organigram Global's score of 0.94 indicating that SNDL is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer OGI or TLRY?

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 125.05%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media prefer OGI or TLRY?

In the previous week, Tilray Brands had 11 more articles in the media than Organigram Global. MarketBeat recorded 13 mentions for Tilray Brands and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Tilray Brands' score of 0.29 indicating that Organigram Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tilray Brands 3 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Organigram Global (OGI) Competitors

$1.06 -0.03 (-2.75%)

Closing price 04:00 PM Eastern

Extended Trading

$1.08 +0.02 (+2.36%)

As of 07:42 PM Eastern

Compare

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? MarketBeat compares Organigram Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Organigram Global compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.46%	-0.04%	-0.03%
Organigram Global	-9.22%	-13.41%	-9.09%

Aurora Cannabis has higher revenue and earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$246.72M	0.82	$1.63M	-$1.08	N/A
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A

In the previous week, Aurora Cannabis had 3 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Aurora Cannabis and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Aurora Cannabis' score of 0.75 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

Summary

Aurora Cannabis beats Organigram Global on 8 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Organigram Global (NASDAQ:OGI) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -94.39%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Canopy Growth	-94.39%	-46.85%	-28.95%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Canopy Growth had 8 more articles in the media than Organigram Global. MarketBeat recorded 10 mentions for Canopy Growth and 2 mentions for Organigram Global. Canopy Growth's average media sentiment score of 1.01 beat Organigram Global's score of 0.94 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	5 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Organigram Global has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

Organigram Global has higher earnings, but lower revenue than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A
Canopy Growth	$225.65M	1.84	-$429.86M	-$1.30	N/A

Summary

Organigram Global beats Canopy Growth on 8 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Organigram Global	-9.22%	-13.41%	-9.09%

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 7.8% of Cronos Group shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cronos Group presently has a consensus target price of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Cronos Group and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Cronos Group's score of 0.63 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	6.92	-$9.45M	$0.01	271.00
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A

Cronos Group has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market.

Summary

Cronos Group beats Organigram Global on 10 of the 15 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

SNDL (NASDAQ:SNDL) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

In the previous week, SNDL had 4 more articles in the media than Organigram Global. MarketBeat recorded 6 mentions for SNDL and 2 mentions for Organigram Global. SNDL's average media sentiment score of 1.06 beat Organigram Global's score of 0.94 indicating that SNDL is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 254.61%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Organigram Global	-9.22%	-13.41%	-9.09%

34.6% of Organigram Global shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

SNDL has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Summary

SNDL beats Organigram Global on 9 of the 16 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Organigram Global (NASDAQ:OGI) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, Tilray Brands had 11 more articles in the media than Organigram Global. MarketBeat recorded 13 mentions for Tilray Brands and 2 mentions for Organigram Global. Organigram Global's average media sentiment score of 0.94 beat Tilray Brands' score of 0.29 indicating that Organigram Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	3 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Comparatively, 0.8% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Tilray Brands	-156.51%	-3.31%	-2.42%

Organigram Global has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 125.05%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Organigram Global has higher earnings, but lower revenue than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.81	-$17.70M	-$0.13	N/A
Tilray Brands	$821.31M	0.73	-$2.19B	-$13.65	N/A

Summary

Tilray Brands beats Organigram Global on 9 of the 16 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$149.22M	$7.86B	$6.45B	$12.42B
Dividend Yield	N/A	2.56%	2.69%	5.29%
P/E Ratio	-8.15	15.39	22.30	24.19
Price / Sales	0.81	5.69	581.44	138.36
Price / Cash	N/A	17.23	42.31	57.88
Price / Book	0.57	3.53	9.84	6.72
Net Income	-$17.70M	$224.05M	$3.57B	$337.19M
7 Day Performance	-4.50%	-1.09%	-1.16%	0.48%
1 Month Performance	-25.35%	0.34%	3.85%	5.07%
1 Year Performance	-20.30%	-0.29%	27.40%	34.25%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OGI Organigram Global	0.7715 of 5 stars	$1.06 -2.8%	N/A	-16.8%	$149.22M	$185.07M	N/A	1,139
ACB Aurora Cannabis	0.7947 of 5 stars	$3.46 flat	N/A	-32.6%	$204.52M	$246.72M	N/A	1,130	News Coverage
CGC Canopy Growth	2.1801 of 5 stars	$1.05 +1.0%	N/A	-12.4%	$424.33M	$225.65M	N/A	3,150	News Coverage Positive News Analyst Upgrade
CRON Cronos Group	1.5809 of 5 stars	$2.73 -0.4%	$2.30 -15.8%	+42.2%	$1.03B	$146.59M	273.27	450
SNDL SNDL	3.4662 of 5 stars	$1.44 -0.7%	$5.00 +247.2%	+13.4%	$370.66M	$677.32M	N/A	2,751	News Coverage Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Do institutionals and insiders believe in ACB or OGI?

Do analysts rate ACB or OGI?

Is ACB or OGI more profitable?

Which has stronger valuation and earnings, ACB or OGI?

Does the media refer more to ACB or OGI?

Which has more volatility and risk, ACB or OGI?

Summary

How does Organigram Global compare to Canopy Growth?

Is OGI or CGC more profitable?

Do analysts prefer OGI or CGC?

Does the media favor OGI or CGC?

Do institutionals and insiders have more ownership in OGI or CGC?

Which has more volatility & risk, OGI or CGC?

Which has stronger earnings & valuation, OGI or CGC?

Summary

How does Organigram Global compare to Cronos Group?

Is CRON or OGI more profitable?

Do institutionals and insiders believe in CRON or OGI?

Do analysts prefer CRON or OGI?

Does the media prefer CRON or OGI?

Which has better earnings and valuation, CRON or OGI?

Which has more risk & volatility, CRON or OGI?

Summary

How does Organigram Global compare to SNDL?

Does the media favor SNDL or OGI?

Which has better earnings and valuation, SNDL or OGI?

Do analysts recommend SNDL or OGI?

Is SNDL or OGI more profitable?

Do insiders & institutionals believe in SNDL or OGI?

Which has more risk & volatility, SNDL or OGI?

Summary

How does Organigram Global compare to Tilray Brands?

Does the media prefer OGI or TLRY?

Do insiders and institutionals hold more shares of OGI or TLRY?

Is OGI or TLRY more profitable?

Which has more risk and volatility, OGI or TLRY?

Do analysts prefer OGI or TLRY?

Which has stronger earnings and valuation, OGI or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools